Squarepoint
PMVP icon

Squarepoint’s PMV Pharmaceuticals PMVP Stock Holding History

Squarepoint’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.7K Buy
31,833
+4,452
+16% +$5.71K ﹤0.01% 4276
2026
Q1 		$34K Buy
27,381
+879
+3% +$1.12K ﹤0.01% 4164
2025
Q4 		$33.1K Buy
26,502
+13,367
+102% +$17.9K ﹤0.01% 4150
2025
Q3 		$18.4K Sell
13,135
-7,770
-37% -$10.7K ﹤0.01% 4291
2025
Q2 		$22.2K Sell
20,905
-991
-5% -$972 ﹤0.01% 4386
2025
Q1 		$23.9K Sell
21,896
-51,119
-70% -$69.4K ﹤0.01% 4426
2024
Q4 		$110K Buy
73,015
+29,722
+69% +$47.1K ﹤0.01% 4675
2024
Q3 		$64.5K Sell
43,293
-7,831
-15% -$12.1K ﹤0.01% 3950
2024
Q2 		$82.8K Buy
+51,124
New +$92.2K ﹤0.01% 3832
2023
Q3 		– Sell
-19,041
Closed -$119K – 4130
2023
Q2 		$119K Sell
19,041
-237,522
-93% -$1.24M ﹤0.01% 3328
2023
Q1 		$1.22M Buy
256,563
+238,395
+1,312% +$1.68M 0.01% 1763
2022
Q4 		$158K Sell
18,168
-21,603
-54% -$230K ﹤0.01% 2861
2022
Q3 		$473K Buy
39,771
+12,300
+45% +$178K ﹤0.01% 2228
2022
Q2 		$391K Sell
27,471
-6,585
-19% -$95.8K ﹤0.01% 2136
2022
Q1 		$709K Buy
34,056
+6,601
+24% +$116K ﹤0.01% 1804
2021
Q4 		$634K Buy
+27,455
New +$663K ﹤0.01% 1993
2020
Q4 		– Sell
-22,156
Closed -$787K – 3185
2020
Q3 		$787K Buy
+22,156
New +$815K 0.01% 1125

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Squarepoint's PMVP Position: Q2 2026 in Review

Squarepoint increased its PMV Pharmaceuticals (PMVP) stake by 16% in Q2 2026, buying an estimated $5.71K and bringing the position to 31,833 shares worth $42.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4276.

Squarepoint first reported a position in PMVP in Q3 2020 and has held it in 17 quarters since. The position peaked at $1.22M in Q1 2023. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • Squarepoint held 31,833 shares of PMV Pharmaceuticals worth $42.7K as of Q2 2026.
  • Squarepoint bought 4,452 PMV Pharmaceuticals shares in Q2 2026, an estimated $5.71K.
  • PMV Pharmaceuticals made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4276 holding.
  • Squarepoint first reported a position in PMV Pharmaceuticals in Q3 2020 and has held it in 17 quarters since.
  • Squarepoint's PMV Pharmaceuticals position peaked at $1.22M in Q1 2023.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.